- Home
- Publications
- Publication Search
- Publication Details
Title
Natalizumab during pregnancy and lactation
Authors
Keywords
-
Journal
Multiple Sclerosis Journal
Volume -, Issue -, Pages 135245851772881
Publisher
SAGE Publications
Online
2017-08-31
DOI
10.1177/1352458517728813
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evaluation of pregnancy outcomes from the Tysabri® (natalizumab) pregnancy exposure registry: a global, observational, follow-up study
- (2016) Susan Friend et al. BMC Neurology
- New insights into the pharmacokinetics and pharmacodynamics of natalizumab treatment for patients with multiple sclerosis, obtained from clinical and in vitro studies
- (2016) T. Sehr et al. Journal of Neuroinflammation
- Transfer of Natalizumab into Breast Milk in a Mother with Multiple Sclerosis
- (2015) Teresa E. Baker et al. JOURNAL OF HUMAN LACTATION
- Normal outcome of pregnancy with ongoing treatment with natalizumab
- (2014) J. Fagius et al. ACTA NEUROLOGICA SCANDINAVICA
- Therapeutic monoclonal antibodies in human breast milk
- (2014) Elle Ross et al. MELANOMA RESEARCH
- Pregnancy and fetal outcomes following natalizumab exposure in pregnancy. A prospective, controlled observational study
- (2014) Neda Ebrahimi et al. Multiple Sclerosis Journal
- Natalizumab Use During the Third Trimester of Pregnancy
- (2014) Aiden Haghikia et al. JAMA Neurology
- Natalizumab treatment during pregnancy - effects on the neonatal immune system
- (2012) H. Schneider et al. ACTA NEUROLOGICA SCANDINAVICA
- Natalizumab
- (2012) Richard Rudick et al. JAMA Neurology
- Accidental natalizumab administration to the third trimester of pregnancy in an adolescent patient with multiple sclerosis
- (2011) A. Bayas et al. ACTA NEUROLOGICA SCANDINAVICA
- Transplacental Transfer of Immunosuppressants and Biologics Used for the Treatment of Inflammatory Bowel Disease
- (2011) Maria Chaparro et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Pregnancy and natalizumab: results of an observational study in 35 accidental pregnancies during natalizumab treatment
- (2011) Kerstin Hellwig et al. Multiple Sclerosis Journal
- Perspectives on Immunoglobulins in Colostrum and Milk
- (2011) Walter L. Hurley et al. Nutrients
- Embryo/fetal development in cynomolgus monkeys exposed to natalizumab, an α4 integrin inhibitor
- (2009) Nancy G. Wehner et al. BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY
- Postnatal development in cynomolgus monkeys following prenatal exposure to natalizumab, an α4 integrin inhibitor
- (2009) Nancy G. Wehner et al. BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY
- Effects of natalizumab, an α4 integrin inhibitor, on the development of Hartley guinea pigs
- (2009) Nancy G. Wehner et al. BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY
- Receptor-mediated uptake and transport of macromolecules in the human placenta
- (2009) Henning Schneider et al. INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search